Poolbeg Pharma Plc
Initial results having completed our POLB 001 LPS human challenge clinical trial
SPONSORED
By Elric Langton | 12 December 2022
I have a financial interest in Poolbeg Pharma.
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a leading infectious disease-focused biopharmaceutical company, informed the market today it had received the initial results having completed our POLB 001 LPS human challenge clinical trial, on schedule, with no serious adβ¦